卢拉西在西班牙的使用和剂量:RETROLUR,使用人工智能进行现实世界的回顾性分析
Fernando Mora1,2, Carlos Gómez Sánchez-Lafuente3, Mariano De Iceta4,5,6
1Department of Psychiatry and Mental Health, Hospital Universitario Infanta Leonor, Madrid, Spain.
Frontiers in psychiatry
|February 27, 2025
概括
卢拉西有效地减少了精神分裂症和双极性抑郁症的症状,具有良好的安全性. 然而,在西班牙使用的低剂量可能会限制其充分的治疗潜力.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 现实世界的证据.
背景情况:
- 卢拉西被批准用于治疗精神分裂症和双极性抑郁症.
- 有限的现实世界数据存在于卢拉西的使用,有效性和安全性.
- 电子健康记录 (EHR) 为真实世界的数据提供了宝贵的来源.
研究的目的:
- 通过使用EHRs的现实数据来描述用卢拉西治疗的患者.
- 在西班牙的常规临床实践中评估卢拉西的疗效和安全性.
- 分析卢拉西使用者的社会人口统计学,临床和治疗特征.
主要方法:
- 多中心,回顾性,观察性研究.
- 从开始服用卢拉西的患者的EHR中提取的数据 (2019年9月 - 2022年3月).
- 自然语言处理 (NLP) 和机器学习用于分析非结构化临床数据.
主要成果:
- 272名患者开始服用卢拉西;中位数年龄46岁,60.3%为女性.
- 以前使用过抗精神病药物的高率 (87.1%);常见的并发病包括高血压,脂质失调和糖尿病.
- 卢拉西在减少积极/消极症状,焦虑,抑郁和自杀念头方面表现出有效性,具有有利的安全性.
结论:
- 卢拉西在现实环境中显示出有效性和良好的安全性.
- 低停药率表明有效性-耐受性平衡和患者满意度良好.
- 与临床试验相比,在西班牙低剂量的lurasidone使用可能会限制其观察到的益处.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications